TUMI

TUMI Genomics is a private biotechnology and diagnostics company focused on pathogen detection and prevention for the legal cannabis cultivation industry rather than human therapeutics. The company offers laboratory and on-site testing solutions, including quantitative PCR-based pathogen assays, to help cultivators identify and manage crop infections such as hop latent viroid and other plant pathogens. TUMI Genomics also provides data-driven pathogen prevention programs, SOP development, and scientific support intended to improve crop health, yields, and operational consistency. Its current business appears centered on commercial cannabis diagnostics and cultivation-support services, supported by an internal R&D effort and selected research collaborations.